Literature DB >> 21450920

The international workshop on meibomian gland dysfunction: report of the clinical trials subcommittee.

Penny A Asbell1, Fiona J Stapleton, Kerstin Wickström, Esen K Akpek, Pasquale Aragona, Reza Dana, Michael A Lemp, Kelly K Nichols.   

Abstract

Mesh：

Year:  2011        PMID： 21450920      PMCID： PMC3072164          DOI： 10.1167/iovs.10-6997h

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN： 0146-0404            Impact factor:   4.799


× No keyword cloud information.
  28 in total

1.  Oral erythromycin treatment for childhood blepharokeratitis.

Authors:  D M Meisler; M B Raizman; E I Traboulsi
Journal:  J AAPOS       Date:  2000-12       Impact factor: 1.220

2.  Improvement of tear stability following warm compression in patients with meibomian gland dysfunction.

Authors:  Eiki Goto; Koji Endo; Atsushi Suzuki; Yoshiaki Fujikura; Kazuo Tsubota
Journal:  Adv Exp Med Biol       Date:  2002       Impact factor: 2.622

3.  Conservative treatment of meibomian gland dysfunction.

Authors:  Juan M Romero; Seth A Biser; Henry D Perry; David H Levinson; Sima J Doshi; Anthony Terraciano; Eric D Donnenfeld
Journal:  Eye Contact Lens       Date:  2004-01       Impact factor: 2.018

4.  Increase in tear film lipid layer thickness following treatment with warm compresses in patients with meibomian gland dysfunction.

Authors:  Mary Catherine Olson; Donald R Korb; Jack V Greiner
Journal:  Eye Contact Lens       Date:  2003-04       Impact factor: 2.018

5.  Low-concentration homogenized castor oil eye drops for noninflamed obstructive meibomian gland dysfunction.

Authors:  Eiki Goto; Jun Shimazaki; Yu Monden; Yoji Takano; Yukiko Yagi; Shigeto Shimmura; Kazuo Tsubota
Journal:  Ophthalmology       Date:  2002-11       Impact factor: 12.079

6.  Treatment of non-inflamed obstructive meibomian gland dysfunction by an infrared warm compression device.

Authors:  E Goto; Y Monden; Y Takano; A Mori; S Shimmura; J Shimazaki; K Tsubota
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

7.  Disposable eyelid-warming device for the treatment of meibomian gland dysfunction.

Authors:  Asako Mori; Jun Shimazaki; Shigeto Shimmura; Hiroshi Fujishima; Yoshihisa Oguchi; Kazuo Tsubota
Journal:  Jpn J Ophthalmol       Date:  2003 Nov-Dec       Impact factor: 2.447

8.  Minocycline effect on meibomian gland lipids in meibomianitis patients.

Authors:  W E Shine; J P McCulley; A G Pandya
Journal:  Exp Eye Res       Date:  2003-04       Impact factor: 3.467

9.  Classification of chronic blepharitis.

Authors:  J P McCulley; J M Dougherty; D G Deneau
Journal:  Ophthalmology       Date:  1982-10       Impact factor: 12.079

10.  Efficacy of topical cyclosporine for the treatment of ocular rosacea.

Authors:  Barry A Schechter; Randy S Katz; Lee S Friedman
Journal:  Adv Ther       Date:  2009-06-23       Impact factor: 3.845
View more
  18 in total

1.  Rasch analysis of the Ocular Surface Disease Index (OSDI).

Authors:  Bradley E Dougherty; Jason J Nichols; Kelly K Nichols
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-07       Impact factor: 4.799

2.  Tear eicosanoids in healthy people and ocular surface disease.

Authors:  Yohannes Abere Ambaw; Cecilia Chao; Shanshan Ji; Manfred Raida; Federico Torta; Markus R Wenk; Louis Tong
Journal:  Sci Rep       Date:  2018-07-26       Impact factor: 4.379

3.  A novel noninvasive ocular surface analyzer for the assessment of dry eye with Meibomian gland dysfunction.

Authors:  Yuanyuan Qi; Chen Zhang; Shaozhen Zhao; Yue Huang; Ruibo Yang
Journal:  Exp Ther Med       Date:  2017-04-19       Impact factor: 2.447

4.  Validity of subjective assessment as screening tool for dry eye disease and its association with clinical tests.

Authors:  Kavita R Bhatnagar; Sonali Pote; Sudeep Pujari; Dhiraj Deka
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

Review 5.  Topical treatments for blepharokeratoconjunctivitis in children.

Authors:  Michael O'Gallagher; Catey Bunce; Melanie Hingorani; Frank Larkin; Stephen Tuft; Annegret Dahlmann-Noor
Journal:  Cochrane Database Syst Rev       Date:  2017-02-07

Review 6.  Topical corticosteroids for dry eye.

Authors:  Su-Hsun Liu; Ian J Saldanha; Alison G Abraham; Thanitsara Rittiphairoj; Scott Hauswirth; Darren Gregory; Cristos Ifantides; Tianjing Li
Journal:  Cochrane Database Syst Rev       Date:  2022-10-21

Review 7.  Systemic treatment for blepharokeratoconjunctivitis in children.

Authors:  Michael O'Gallagher; Marina Banteka; Catey Bunce; Frank Larkin; Stephen Tuft; Annegret Dahlmann-Noor
Journal:  Cochrane Database Syst Rev       Date:  2016-05-30

8.  In vivo Confocal Microscopy Evaluation of Meibomian Gland Dysfunction in Dry Eye Patients with Different Symptoms.

Authors:  Hui Zhao; Jing-Yao Chen; Yu-Qian Wang; Zhi-Rong Lin; Shen Wang
Journal:  Chin Med J (Engl)       Date:  2016-11-05       Impact factor: 2.628

9.  Evaluation of the Safety and Effectiveness of Intense Pulsed Light in the Treatment of Meibomian Gland Dysfunction.

Authors:  Xiaodan Jiang; Huibin Lv; Hang Song; Mingzhou Zhang; Yan Liu; Xiaodan Hu; Xuemin Li; Wei Wang
Journal:  J Ophthalmol       Date:  2016-06-20       Impact factor: 1.909

10.  Total cholesterol and lipoprotein composition are associated with dry eye disease in Korean women.

Authors:  Yoon Hong Chun; Hye Rang Kim; Kyungdo Han; Yong-Gyu Park; Ho Jin Song; Kyung-Sun Na
Journal:  Lipids Health Dis       Date:  2013-06-05       Impact factor: 3.876
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.